Hangzhou Coco Healthcare Products Co.,Ltd.
SZSE:301009.SZ
11.3 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 1,081.484 | 1,186.29 | 1,186.404 | 1,635.132 | 1,173.726 | 906.242 | 786.938 |
| Cost of Revenue
| 890.561 | 1,030.899 | 965.309 | 1,180.106 | 856.564 | 675.446 | 561.947 |
| Gross Profit
| 190.924 | 155.391 | 221.094 | 455.026 | 317.162 | 230.796 | 224.991 |
| Gross Profit Ratio
| 0.177 | 0.131 | 0.186 | 0.278 | 0.27 | 0.255 | 0.286 |
| Reseach & Development Expenses
| 44.107 | 50.983 | 49.274 | 58.84 | 44.194 | 34.161 | 34.622 |
| General & Administrative Expenses
| 12.65 | 10.646 | 15.171 | -8.837 | -60.803 | -78.726 | -35.725 |
| Selling & Marketing Expenses
| 99.47 | 95.18 | 90.686 | 65.438 | 118.338 | 96.861 | 103.621 |
| SG&A
| 112.12 | 105.826 | 105.858 | 56.601 | 57.535 | 18.135 | 67.896 |
| Other Expenses
| -0.779 | -0.904 | -1.771 | 21.324 | -19.969 | -12.169 | 36.689 |
| Operating Expenses
| 175.169 | 171.278 | 176.792 | 138.783 | 204.549 | 163.358 | 165.961 |
| Operating Income
| 20.232 | -55.468 | 45.302 | 255.389 | 107.953 | 66.197 | 50.125 |
| Operating Income Ratio
| 0.019 | -0.047 | 0.038 | 0.156 | 0.092 | 0.073 | 0.064 |
| Total Other Income Expenses Net
| -0.779 | -0.904 | -1.771 | -1.091 | 0.473 | 3.693 | 2.957 |
| Income Before Tax
| 19.453 | -56.373 | 43.532 | 254.299 | 108.426 | 69.889 | 53.081 |
| Income Before Tax Ratio
| 0.018 | -0.048 | 0.037 | 0.156 | 0.092 | 0.077 | 0.067 |
| Income Tax Expense
| 1.691 | -0.126 | 4.094 | 31.202 | 14.944 | 8.199 | 5.197 |
| Net Income
| 20.185 | -43.129 | 39.745 | 214.01 | 87.451 | 59.682 | 41.857 |
| Net Income Ratio
| 0.019 | -0.036 | 0.034 | 0.131 | 0.075 | 0.066 | 0.053 |
| EPS
| 0.07 | -0.16 | 0.15 | 0.79 | 0.32 | 0.3 | 0.21 |
| EPS Diluted
| 0.07 | -0.16 | 0.15 | 0.79 | 0.32 | 0.3 | 0.21 |
| EBITDA
| 97.607 | 83.719 | 104.267 | 337.363 | 150.777 | 109.513 | 83.435 |
| EBITDA Ratio
| 0.09 | 0.071 | 0.088 | 0.206 | 0.128 | 0.121 | 0.106 |